FDA Updates Its Criteria For Medicare Coverage Of Device Trials
This article was originally published in The Gray Sheet
The agency has long been partnering with CMS to set coverage for investigational device exemption studies by designating IDE trials as "category A" or "category B." A new FDA draft guidance and memorandum of understanding between FDA and CMS are intended to modernize the criteria for those trial categories.
Register for our free email digests: